BGM Group Ltd (BGM)

• Market cap: $708M
• 1 day: -1.4%
• 5 days: -4.08%
• 1 month: -8.31%
• 3 months: -61.29%
• 6 months: -60.86%
• Year to date: -1.4%
• 1 year: -64.02%
• 5 years: -90.36%
• 10 years: -92.94%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.

Employees: 323